Citadel Advisors’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$126M Sell
1,505,161
-70,883
-4% -$5.94M 0.02% 213
2025
Q1
$113M Buy
1,576,044
+603,634
+62% +$43.1M 0.02% 228
2024
Q4
$43.7M Buy
972,410
+950,670
+4,373% +$42.7M 0.01% 597
2024
Q3
$1.1M Buy
21,740
+13,613
+168% +$687K ﹤0.01% 3030
2024
Q2
$332K Buy
+8,127
New +$332K ﹤0.01% 4208
2024
Q1
Hold
0
6765
2023
Q4
Sell
-40,625
Closed -$1.2M 6596
2023
Q3
$1.2M Buy
+40,625
New +$1.2M ﹤0.01% 2874
2022
Q3
Sell
-19,687
Closed -$55K 6637
2022
Q2
$55K Buy
19,687
+10,045
+104% +$28.1K ﹤0.01% 5472
2022
Q1
$32K Sell
9,642
-350
-4% -$1.16K ﹤0.01% 6042
2021
Q4
$61K Sell
9,992
-538
-5% -$3.28K ﹤0.01% 6099
2021
Q3
$146K Buy
10,530
+871
+9% +$12.1K ﹤0.01% 5624
2021
Q2
$165K Buy
9,659
+5,466
+130% +$93.4K ﹤0.01% 5702
2021
Q1
$79K Buy
4,193
+2,837
+209% +$53.5K ﹤0.01% 5945
2020
Q4
$39K Buy
1,356
+382
+39% +$11K ﹤0.01% 4901
2020
Q3
$37K Buy
+974
New +$37K ﹤0.01% 4440
2020
Q2
Hold
0
5234
2019
Q2
Sell
-1,195
Closed -$37K 5055
2019
Q1
$37K Buy
+1,195
New +$37K ﹤0.01% 4306
2018
Q3
Sell
-862
Closed -$30K 4683
2018
Q2
$30K Buy
+862
New +$30K ﹤0.01% 3991
2017
Q4
Sell
-365
Closed -$14K 4246
2017
Q3
$14K Buy
+365
New +$14K ﹤0.01% 3567
2017
Q2
Sell
-327
Closed -$17K 4120
2017
Q1
$17K Buy
+327
New +$17K ﹤0.01% 3554
2016
Q4
Sell
-317
Closed -$23K 4048
2016
Q3
$23K Buy
+317
New +$23K ﹤0.01% 3392
2015
Q3
Sell
-140
Closed -$30K 4263
2015
Q2
$30K Buy
+140
New +$30K ﹤0.01% 3520